PAVmed Inc.
PAVM
$0.6551
-$0.0549-7.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 162.00% | 134.45% | 26.95% | 31.75% | 27.88% |
| Total Depreciation and Amortization | -59.14% | -36.79% | -19.00% | -5.96% | 19.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,085.49% | -894.07% | -64.40% | -63.34% | -53.15% |
| Change in Net Operating Assets | -67.82% | 7.29% | 485.63% | 177.91% | 322.21% |
| Cash from Operations | 35.52% | 20.12% | 26.84% | 35.03% | 26.69% |
| Capital Expenditure | 77.27% | 34.45% | 62.44% | 73.99% | 84.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -165.00% | 100.00% | 100.00% | 100.00% |
| Cash from Investing | -2,235.09% | -2,644.79% | 62.44% | 91.92% | 115.99% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -71.61% |
| Total Debt Repaid | -572.15% | -- | -- | -- | -- |
| Issuance of Common Stock | -7.37% | 12.83% | -4.91% | 86.37% | 142.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.96% | 143.10% | 119.95% | 43.28% | 645.31% |
| Cash from Financing | 0.36% | 39.58% | -4.20% | -59.73% | -18.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.21% | 15.58% | 58.33% | -53.61% | 46.41% |